droxidopa has been researched along with phenylephrine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oyabe, A; Satoh, S; Suzuki-Kusaba, M; Tanno, M | 1 |
| Lyman, CP; O'Brien, RC | 1 |
| Higa, S; Kishimoto, S; Matsumoto, M; Sakoda, S; Suzuki, T; Ueji, M; Yoneda, S | 1 |
| Bartlett, P; Fernandes, K; Hein, L; Jha, S; Jhaveri, D; Ladiwala, U; Marathe, SV; Muthig, V; Rommelfanger, K; Vadodaria, KC; Vaidya, VA; Weinshenker, D; Yanpallewar, SU | 1 |
4 other study(ies) available for droxidopa and phenylephrine
| Article | Year |
|---|---|
Beneficial attenuating effect of L-threo-3,4-dihydroxyphenylserine on postural hypotension in anesthetized rats.
Topics: Anesthesia; Animals; Benzylamines; Blood Pressure; Droxidopa; Hexamethonium Compounds; Male; Phenylephrine; Posture; Rats; Rats, Inbred Strains; Serine; Sympathetic Nervous System; Tyramine | 1989 |
A pharmacological study of hibernation in rodents.
Topics: Adrenalectomy; Amphetamine; Animals; Bromocriptine; Cricetinae; Droxidopa; Epinephrine; Hibernation; Isoproterenol; Levodopa; Mesocricetus; Norepinephrine; Phenylephrine; Sciuridae | 1988 |
Treatment of orthostatic hypotension in Shy-Drager syndrome with DL-threo-3,4-dihydroxyphenylserine: a case report.
Topics: Autonomic Nervous System Diseases; Blood Pressure; Carbidopa; Droxidopa; Drug Combinations; Humans; Hypotension, Orthostatic; Male; Middle Aged; Norepinephrine; Phenylephrine; Serine; Shy-Drager Syndrome; Valsalva Maneuver | 1985 |
Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Analysis of Variance; Animals; Animals, Newborn; Antidepressive Agents; Antiparkinson Agents; Ascorbic Acid; Behavior, Animal; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cells, Cultured; Dopamine beta-Hydroxylase; Doublecortin Domain Proteins; Droxidopa; Drug Administration Schedule; Drug Interactions; Embryo, Mammalian; Female; Gene Expression Regulation, Developmental; Hippocampus; Imipramine; In Vitro Techniques; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microtubule-Associated Proteins; Nerve Tissue Proteins; Neurogenesis; Neuropeptides; Phenylephrine; Pregnancy; Prenatal Exposure Delayed Effects; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Reaction Time; Receptors, Adrenergic, alpha-2; Stem Cells; Yohimbine | 2010 |